• Supreme Court Likely To Clarify Standard of Review on District Court's Factual Findings in Support of Patent Claim Construction
  • April 6, 2015
  • Law Firm: Staas Halsey LLP - Washington Office
  • The Supreme Court of the United States (“Supreme Court”) has granted Teva Pharmaceuticals USA’s (“Teva”) petition for review. Teva appealed the decision of the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”). The Federal Circuit had reversed the U.S. District Court for the Southern District of New York (“District Court”).